Trans-muscular quadratus lumborum block for management of post-surgical pain after gall bladder resection

Trans-muscular quadratus lumborum block for post operative analgesia in laparoscopic cholecystectomy: A double blind randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052217

Enrollment

114

Registered

2023-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: Group 1(QLB):: After completion of surgery USG guided trans-muscular quadratus lumborum block will be given using 0.3 ml/kg of 0.25% bupivacaine plain bilaterally. Control Intervention1

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists physical status (ASA) I and II, who are scheduled for laparoscopic cholecystectomy under general anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Patientâ??s refusal 2. Allergies to local anesthetic drugs, 3. body mass index (BMI) >35 Kg/m, 4. Significant cardiovascular disease, hepatic dysfunction or renal dysfunction 5. Coagulation abnormalities, 6. Infection in the intended intervention site, 7. history of laparotomy 8. Inability to communicate. 9. Chronic opioid usage

Design outcomes

Primary

Measure	Time frame
To evaluate the analgesic effect of trans-muscular quadratus block after surgery in the form of visual analogue scale (VAS) score at rest.Timepoint: To evaluate VAS score at 6 hours after intervention	—

Secondary

Measure	Time frame
1. To evaluate the analgesic effect of trans-muscular quadratus block in the form of visual analogue scale (VAS) score at rest and on coughing in 1st 24 hours 2. To compare the duration of block (The time to first analgesic request) which is defined as the time interval between end of LA injection and patients pain complaint (VAS 3). 3. To compare total analgesic consumption in 1st 24 hours. 4. To compare patientâ??s satisfaction 5. To compare complications if any. Timepoint: (VAS) score at rest and on coughing in 1st 24 hours (30 min, 1h, 2h, 4h, 6h, 8h, 12h and 24 h)	—

Measure

Time frame

1. To evaluate the analgesic effect of trans-muscular quadratus block in the form of visual analogue scale (VAS) score at rest and on coughing in 1st 24 hours 2. To compare the duration of block (The time to first analgesic request) which is defined as the time interval between end of LA injection and patients pain complaint (VAS 3). 3. To compare total analgesic consumption in 1st 24 hours. 4. To compare patientâ??s satisfaction 5. To compare complications if any. Timepoint: (VAS) score at rest and on coughing in 1st 24 hours (30 min, 1h, 2h, 4h, 6h, 8h, 12h and 24 h)

—

Countries

India

Contacts

Public ContactDr Priyanka Dwivedi

All India Institute of Medical Sciences Gorakhpur

drpriyad1111@gmail.com8795453444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026